MedPath

Prospective study of protoporphyrin IX fluorescence and spectral detection in digestive malignant tumors

Not Applicable
Recruiting
Conditions
digestive malignant tumor
Registration Number
JPRN-UMIN000023350
Lead Sponsor
Tottori University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with porphyrinemia 2) Patients with hypersensitivity or a medical history with porphyrin related adverse events 3) People who have taken chemotheraphy for malignant tumors within one month before the start of the trial 4) Patients who have had other cancers 5) Patients who are taking anticoagulant or antithrombotic drugs 6) Women who are pregnant or are possibly pregnant 7) Patients with positive HBs antigen or HCV antibody

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath